Two concurrent studies of mouse models harboring the knockin TP53 mutations equivalent to R175H and R273H showed persuasive but conflicting evidence for GOF in vivo, with an increased incidence of carcinomas in R175H/−19 but not R175H/R175H6 mice. The gene discussed is TP53; the disease is carcinoma.